AnalystsSteven Mah
Steven Mah's Stock Forecasts

Analyst Ranking
Bottom 1%
#3565 out of 3582 analysts
Average Return
-36.02%
Win Rate
8%1 out of 13
Risk vs Reward
Poor
Good

Steven Mah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ortho Clinical Diagnostics Holdings plcOCDX
+4.68%$17.11$17.91
2021-02-21 -
2022-01-24
Strong Buy

Steven Mah's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Talis Biomedical CorpTLIS
2Hold$9.00+204.05%Downgrades
5 months ago
Heska CorpHSKA
2Strong Buy$305.00+98.90%Maintains
6 months ago
Natera IncNTRA
2Strong Buy$155.00+140.68%Maintains
7 months ago
Akoya Biosciences IncAKYA
1Strong Buy$28.00+141.38%Initiates Coverage On
8 months ago
Luminex CorpLMNX
1Hold$37.00+0.03%Downgrades
9 months ago
Twist Bioscience CorpTWST
1Strong Buy$150.00+168.48%Initiates Coverage On
9 months ago
Codexis IncCDXS
1Strong Buy$32.00+55.79%Initiates Coverage On
9 months ago
Fulgent Genetics IncFLGT
1Strong Buy$140.00+130.57%Maintains
a year ago
Ortho Clinical Diagnostics Holdings plcOCDX
1Strong Buy$27.00+50.75%Initiates Coverage On
a year ago
Pacific Biosciences Of California IncPACB
1Strong Buy$52.00+387.35%Upgrades
a year ago
Oxford Immunotec Global PLCOXFD
1Hold$22.00N/ADowngrades
a year ago
Oncocyte CorpOCX
1Strong Buy$4.00N/AUpgrades
a year ago
Illumina IncILMN
1Hold$340.00N/ADowngrades
a year ago
Quidel CorpQDEL
1Strong Buy$250.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.